PRAXIS PRECISION MEDICINES, INC. Increase (Decrease) in Accounts Payable
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Increase (Decrease) in Accounts Payable of -$1.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$7.88M, a 233.07% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $6.53M, a 37.10% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$6.19M.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.99M, a 71.64% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in accounts payable for fiscal 2025 was $12.10M, a 80.20% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in accounts payable for fiscal 2024 was $6.71M.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in accounts payable for fiscal 2023 was -$8.86M, a 327.52% decline from fiscal 2022.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in accounts payable for fiscal 2022 was $3.89M, a 46.44% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.35M 10-Q · filed 2026-08-06 | -$7.55M derived: sum of 3 quarters · filed 2026-08-06 | -$5.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $6.53M 10-Q · filed 2026-05-07 | $336.00K derived: sum of 2 quarters · filed 2026-05-07 | $2.32M derived: sum of 3 quarters · filed 2026-05-07 | $8.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$4.21M derived: sum of 2 quarters · filed 2026-02-19 | $1.72M derived: sum of 3 quarters · filed 2026-08-06 | $12.10M 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.91M derived: sum of 2 quarters · filed 2026-08-06 | $18.29M 10-Q · filed 2025-11-05 | $15.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $5.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $16.30M 10-Q · filed 2026-08-06 | $13.82M derived: sum of 3 quarters · filed 2026-08-06 | $20.83M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $10.38M 10-Q · filed 2026-05-07 | $7.90M derived: sum of 2 quarters · filed 2026-05-07 | $14.90M derived: sum of 3 quarters · filed 2026-05-07 | $13.51M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.52M derived: sum of 2 quarters · filed 2026-02-19 | $3.12M derived: sum of 3 quarters · filed 2026-02-19 | $6.71M 10-K · filed 2026-02-19 |
| 2024-09-30 | $7.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.61M derived: sum of 2 quarters · filed 2025-11-05 | $9.20M 10-Q · filed 2025-11-05 | $7.90M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $2.19M 10-Q · filed 2025-08-04 | $890.00K derived: sum of 3 quarters · filed 2026-02-19 | -$4.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $3.59M 10-Q · filed 2025-05-02 | $2.29M derived: sum of 2 quarters · filed 2026-02-19 | $1.40M derived: sum of 3 quarters · filed 2026-02-19 | -$7.58M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$2.19M derived: sum of 2 quarters · filed 2026-02-19 | -$11.17M derived: sum of 3 quarters · filed 2026-02-19 | -$8.86M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$894.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$9.87M derived: sum of 2 quarters · filed 2024-11-06 | -$7.56M 10-Q · filed 2024-11-06 | -$3.01M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$8.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$6.66M 10-Q · filed 2024-08-13 | -$2.11M derived: sum of 3 quarters · filed 2024-08-13 | -$3.81M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $2.31M 10-Q · filed 2024-05-13 | $6.86M derived: sum of 2 quarters · filed 2024-05-13 | $5.17M derived: sum of 3 quarters · filed 2024-05-13 | $3.72M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $2.85M derived: sum of 2 quarters · filed 2024-03-05 | $1.40M derived: sum of 3 quarters · filed 2024-03-05 | $3.89M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$3.15M derived: sum of 2 quarters · filed 2023-11-07 | -$658.00K 10-Q · filed 2023-11-07 | $2.58M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.04M 10-Q · filed 2023-08-09 | $4.28M derived: sum of 3 quarters · filed 2023-08-09 | $4.60M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $2.49M 10-Q · filed 2023-05-11 | $5.72M derived: sum of 2 quarters · filed 2023-05-11 | $6.05M derived: sum of 3 quarters · filed 2023-05-11 | $7.55M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $3.56M derived: sum of 2 quarters · filed 2023-02-07 | $5.06M derived: sum of 3 quarters · filed 2023-02-07 | $7.27M 10-K · filed 2023-02-07 |
| 2021-09-30 | $323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.82M derived: sum of 2 quarters · filed 2022-11-09 | $4.03M 10-Q · filed 2022-11-09 | $4.45M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.71M 10-Q · filed 2022-08-08 | $4.12M derived: sum of 3 quarters · filed 2022-08-08 | $3.76M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $2.21M 10-Q · filed 2022-05-09 | $2.62M derived: sum of 2 quarters · filed 2022-05-09 | $2.26M derived: sum of 3 quarters · filed 2022-05-09 | $2.18M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $48.00K derived: sum of 2 quarters · filed 2022-02-28 | -$31.00K derived: sum of 3 quarters · filed 2022-02-28 | $960.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | -$368.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$447.00K derived: sum of 2 quarters · filed 2021-11-03 | $544.00K 10-Q · filed 2021-11-03 | $63.00K derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | -$79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $912.00K 10-Q · filed 2021-08-16 | $431.00K derived: sum of 3 quarters · filed 2021-08-16 | |
| 2020-03-31 | $991.00K 10-Q · filed 2021-05-11 | $510.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | -$481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$837.00K 10-K · filed 2021-03-17 | ||
| 2019-09-30 | -$356.00K 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |